Your institution may have access to this item. Find your institution then sign in to continue.
Title
Exelixis slashes 70% of staff.
Abstract
The article reports on the announcement of drug company Exelixis Inc. in September 2014 that it will cut 160 jobs due to failed results of its prostate cancer drug Cometriq.